Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
rachel.shaw@oncology.ox.ac.uk

Telephone
01865 617078

Address
Oncology Clinical Trials Office (OCTO), Department of Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Headington, Oxford. OX3 7DQ

Rachel Shaw

Trial Manager -Oncology Clinical Trials Office (OCTO)

Rachel joined OCTO in 2016 having previously worked in respiratory trials for 6 years.

Recent publications

Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: The phase 1/randomised phase 2 SCALOP-2 trial.
Journal article

Mukherjee S. et al, (2024), Eur J Cancer, 209

More publications